114991-70-7

Basic information

• Product Name: 3-METHOXY-4-(2-METHOXY-ETHOXY)-BENZALDEHYDE
• Synonyms: 3-METHOXY-4-(2-METHOXY-ETHOXY)-BENZALDEHYDE;AKOS BC-2017;TIMTEC-BB SBB011245
• CAS NO: 114991-70-7
• Molecular Formula: C₁₁H₁₄O₄
• Molecular Weight: 210.23
• Mol File: 114991-70-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-METHOXY-4-(2-METHOXY-ETHOXY)-BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-4-(2-METHOXY-ETHOXY)-BENZALDEHYDE(114991-70-7)
• EPA Substance Registry System: 3-METHOXY-4-(2-METHOXY-ETHOXY)-BENZALDEHYDE(114991-70-7)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 114991-70-7(Hazardous Substances Data)

Upstream product

• 121-33-5 vanillin 
• 6482-24-2 2-Bromoethyl methyl ether 
• 627-42-9 2-chloroethyl methyl ether 

Downstream Products

• 609343-55-7 5-methoxy-4-(2-methoxy-ethoxy)-2-nitro-benzaldehyde 
• 107697-99-4 2,4-diamino-5-(3-methoxy-4-methoxyethoxy-benzyl)-pyrimidine 
• 885597-64-8 5-{1-[3-methoxy-4-(2-methoxy-ethoxy)-phenyl]-methylidene}-2-thioxothiazolidin-4-one 
• 870959-50-5 5-methoxy-4-(2-methoxyethoxy)-2-nitrobenzonitrile 
• 247569-96-6 3-methoxy-4-(2-methoxyethoxy)benzonitrile 

Relevant articles and documents

Styryl xanthine derivatives and uses thereof (by machine translation)

The invention discloses styryl xanthine derivatives and application, and particularly, relates to a novel styryl xanthine derivative and a pharmaceutical composition containing the same, and can be used as selective adenosine A. 2A Are antagoni

CARBOXYLIC ACID ARYL AMIDES

Compounds of formula and pharmaceutically acceptable salts thereof are described, as well as the pharmaceutical compositions containing said compounds and their pharmaceutically acceptable salts, and the use of said compounds and pharmaceutical compositions for the treatment, control or amelioration of proliferative diseases, including cancer.

3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS

Compounds of formula (I) are provided as well as compositions and methods of using compounds of formula (I) for modulating the activity of the estrogen-related receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder related to the activity of the estrogen-related receptor. Considering the wide range of activity of the nuclear hormone receptor ERRα, the compounds described herein which are capable of modulating ERRα activity, are useful for treating a range of disease states including cancer, diabetes, obesity, hyperlipidermia, arthritis, atherosclerosis, osteoporosis, anxiety, depression, Parkinson’s disease and Alzheimer’s disease. Formula (I). The substituents are defined in the claims.